Search company, investor...

Founded Year



Convertible Note | Alive

Total Raised


Last Raised

$150K | 2 mos ago

About Happitech

Happitech develops a heart rhythm software development kit for Android and iPhone operating systems. The company offers algorithms allowing medical-grade vital signs monitoring directly through a smartphone. The company was founded in 2015 and is based in Rotterdam, Netherlands.

Headquarters Location

Hofplein 20

Rotterdam, 3032AC,


+31 97010253612



Happitech Patents

Happitech has filed 1 patent.

The 3 most popular patent topics include:

  • cardiac arrhythmia
  • data management
  • dec hardware
patents chart

Application Date

Grant Date


Related Topics



Sensors, Cardiac arrhythmia, DEC hardware, Data management, Minicomputers


Application Date


Grant Date


Related Topics

Sensors, Cardiac arrhythmia, DEC hardware, Data management, Minicomputers



Latest Happitech News

HeartX Accelerator Announces Five Startup Companies Selected for the 2023 Program

Oct 16, 2023

News provided by Share this article Share toX BENTONVILLE, Ark., Oct. 16, 2023 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom along with eleven leading cardiology practices in Arkansas and around the country — has selected the five startup healthcare companies that will participate in the 2023 accelerator program. HeartX is a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market. The five companies selected for the 2023 HeartX program are: Flosonics Medical, Canada Flosonics Medical produces the FloPatch, a wireless, wearable Doppler ultrasound that directly assesses carotid arterial pulse within seconds. Data from the FloPatch provides a window to the left ventricle, which helps clinicians determine when a patient is no longer fluid-responsive, avoiding harmful and ineffective IV fluids. Learn more at . Happitech, Netherlands Happitech offers an accessible and scalable solution for identifying patients at risk of atrial fibrillation (AF). By placing a finger on a smartphone's camera for 90 seconds, individuals can screen for AF with a sensitivity and specificity similar to the standard of care. This is well suited for at-risk underserved populations, the elderly, and low-income individuals promoting improved health equity. Learn more at . MindMics, Massachusetts, United States MindMics delivers heart monitoring through low-frequency acoustical vibrations detected in the ear canal with technology embedded in earbuds and hearing aids. The results are highly accurate regardless of skin tone, skin thickness, and body mass. The sound-based technology has been clinically validated in collaboration with leading researchers and world-renowned medical institutions. Learn more at . Nanowear, New York, United States Nanowear is an AI-based remote diagnostics tool utilizing proprietary patented cloth-based nanotechnology. The nanosensors capture over 85 medical-grade biomarkers directly from the skin, enabling a closed-loop digital system for specific machine-learning algorithms built on terabytes of unique human data. Learn more at . SmartCardia, Switzerland SmartCardia produces the 7L Patch, a revolutionary platform and 7-Lead ECG patch for cardiology and remote patient monitoring (RPM) that is a breakthrough 7/14 day patch offering real-time 7-Lead ECG and vitals with SaaS. A single patch serves multiple service types: Mobile Cardiac Telemetry, RPM, Holter, Extended Holter, and Event Monitoring. Learn more at . "We are excited to reveal the 2023 HeartX cohort companies, which were hand-selected by our participating cardiology practices," said Jeff Stinson, director of HealthTech Arkansas. "With MedAxiom's help, we've been able to grow the HeartX program to international prominence. Through the guaranteed clinical engagement and the national visibility provided through MedAxiom's national network of cardiology practices, we're now attracting the very best cardiovascular startups from around the world. We're very grateful for this opportunity." "The cardiovascular industry has been at the forefront of healthcare innovation and new technologies and solutions are arising at a rapid pace. We're excited to partner with five companies that are transforming cardiovascular care around the world as part of the 2023 HeartX program. While the heart of the program remains in Arkansas, we've expanded clinical trial sites nationwide to advance innovations that promise to improve care delivery. With two cohorts and ten companies now a part of HeartX, MedAxiom and HealthTech Arkansas are committed to expanding the portfolio to provide revolutionary solutions to patients, providers and programs." said Joe Sasson, PhD, MedAxiom's chief commercial officer and executive vice president of Ventures. Representatives from each of the eleven cardiology practices, plus representatives from HealthTech Arkansas and MedAxiom, interviewed applicants and selected companies with technologies that have the potential to advance cardiovascular innovation and cardiac care at their respective organizations. Each company will receive $150,000 of investment capital as well as complete and total access to clinicians and administrators while executing their pilot projects and clinical studies in the HeartX program. More information about HeartX can be found at . ABOUT HEALTHTECH ARKANSAS HealthTech Arkansas helps to drive innovation for healthcare provider organizations through its accelerator programs and through internal innovation programming. Its flagship accelerator, HeartX, recruits worldwide for the most accomplished cardiovascular-focused startups in the areas of digital health, medical devices, and diagnostic platforms. Those companies accepted into the program are guaranteed at least two pilot projects or clinical trials from among the ten largest hospitals and health systems in Arkansas. More information can be found at . ABOUT MEDAXIOM MedAxiom, an American College of Cardiology Company, is the cardiovascular community's premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of hundreds of cardiovascular organization members, thousands of administrators, clinicians and revenue cycle experts, and dozens of industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience. Learn more at . For more information, contact:

Happitech Frequently Asked Questions (FAQ)

  • When was Happitech founded?

    Happitech was founded in 2015.

  • Where is Happitech's headquarters?

    Happitech's headquarters is located at Hofplein 20, Rotterdam.

  • What is Happitech's latest funding round?

    Happitech's latest funding round is Convertible Note.

  • How much did Happitech raise?

    Happitech raised a total of $150K.

  • Who are the investors of Happitech?

    Investors of Happitech include HeartX Accelerator, University of Edinburgh AI Accelerator, MedTech Innovator and Kickstart Accelerator.

  • Who are Happitech's competitors?

    Competitors of Happitech include Avertix, Tricog Health, Eko, AliveCor, Coala Life and 7 more.


Compare Happitech to Competitors


Wellysis is a company focused on transforming healthcare from CURE to CARE, operating in the healthcare technology sector. The company offers a continuous ECG/EKG monitor that uses AI reporting to assist physicians in diagnosing in a faster, cheaper, and more convenient manner. Wellysis primarily serves the healthcare industry. It was founded in 2019 and is based in Seoul, South Korea.

AliveCor Logo

AliveCor focuses on the creation of machine learning techniques to enable proactive heart care. It offers artificial intelligence (AI) enabled, machine learning (ML) powered electrocardiogram (ECG) sensors that deliver heart data at any time. The company's digital tools help patients access, manage and share their data, and connect with cardiologists to understand and manage their heart health. It was formerly known as AliveUSA. AliveCor was founded in 2011 and is based in Mountain View, California.


CardioDiagnostics offers an end-to-end diagnostic software as a service (SaaS) solution for cardiologists, general practitioners, and patients, to monitor and analyze patients' electrocardiogram (ECG) and heart rate activity live. The company was founded in 2011 and is based in Campbell, California.

InfoBionic Logo

InfoBionic is a company focused on healthcare technology, specifically in the domain of cardiac monitoring. The company offers a mobile cardiac telemetry platform that provides remote cardiac monitoring for various levels of patient acuity. This platform is primarily used in the healthcare industry. The company was founded in 2011 and is based in Chelmsford, Massachusetts.

Peerbridge Health

Peerbridge Health provides healthcare technology designed to advance patient care through remote monitoring. It develops Peerbridge Cor, a cloud-based algorithm that connects patients and medical professionals, and also provides heart rate and rhythm information, and offers continuous vital sign monitoring from home. Peerbridge Health was formerly known as Wireless Live. The company was founded in 2012 and is based in New York, New York.

FibriCheck Logo

FibriCheck offers a screening and monitoring application for irregular heart rhythms including atrial fibrillation. The company provides a mobile solution that measures the user's cardiac rhythm with a smartphone camera. It automatically shares the data with a healthcare professional to streamline diagnosis and treatment. The company was founded in 2014 and is based in Hasselt, Belgium.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.